PT Pyridam Farma Tbk (IDX:PYFA)

Indonesia · Delayed Price · Currency is IDR

214.00

+10.00 (4.90%)

Jul 15, 2026, 4:08 PM WIB

-15.75% (1Y)

Market Cap	2.29T -11.3%
Revenue (ttm)	2.84T +15.8%
Net Income	-369.95B
EPS	-32.83
Shares Out	11.24B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,620,800
Open	206.00
Previous Close	204.00
Day's Range	204.00 - 222.00
52-Week Range	158.00 - 700.00
Beta	0.71
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About PT Pyridam Farma Tbk

PT Pyridam Farma Tbk engages in the pharmaceutical business in Australia, Indonesia, Philippines, Singapore, and India. The company operates through two segments, Pharmaceutical Products, Esthetic and Toll Manufacturing Services; and Medical Equipment segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper. The company also provides... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1976

Employees 2,494

Stock Exchange Indonesia Stock Exchange

Ticker Symbol PYFA

Full Company Profile

Financial Performance

In 2025, PT Pyridam Farma Tbk's revenue was 2.76 trillion, an increase of 43.71% compared to the previous year's 1.92 trillion. Losses were -379.67 billion, 15.0% more than in 2024.

Financial Statements